Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2024HemaSphereOpen Access

Immune‐monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium

View Full Paper
Ask AI
Bookmark
Share

Authors

CTCristina Astrid TentoriLZLin P. ZhaoBTBenedetta Tinterri

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tentori et al. (2024) studied this question.

synapsesocial.com/papers/68e6c052b6db64358764029bhttps://doi.org/10.1002/hem3.64
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Immune-based risk score derived from bulk and single-cell transcriptomics enhances prognostic stratification in MDS2025
  2. 2An Immune Dysfunction Signature Score Predicts Survival in <scp>MDS</scp> Patients: Insights From a Longitudinal, Multicenter Study2026 · 1 citations
  3. 3Improving MDS Risk Assessment: The Role of Monocytopenia and Lymphocytopenia Beyond IPSS-R2025 · 1 citations
  4. 4Treatment of myelodysplastic syndromes in the era of precision medicine and immunomodulatory drugs: a focus on higher-risk disease2022 · 14 citations
  5. 5Searching for a myelodysplastic syndrome stem cells (MDS-SCs) signature by flow cytometry: Toward a new prognostic tool?2025 · 1 citations